SEC Form 5 · accession 0001209191-15-013477
PROTHENA CORP PUBLIC LTD CO · PRTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dale B. Schenk
Officer — President and CEO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 13, 2015 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.01 per shareF1 | Nov 24, 2014 | G | 8,161 | $0.00 | D | 0 | D | |
| Ordinary Shares, par value $0.01 per shareF1,F2 | Nov 24, 2014 | G | 8,161 | $0.00 | A | 8,211 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents transfer of shares to the Schenk Family Trust, dated 2/9/2004, of which Reporting Person is a Co-Trustee with his spouse.
- F2Shares are held by the Schenk Family Trust, dated 2/9/2004, of which Reporting Person is a Co-Trustee with his spouse.